BELANOFF JOSEPH K 4
4 · CORCEPT THERAPEUTICS INC · Filed Sep 4, 2025
Insider Transaction Report
Form 4
BELANOFF JOSEPH K
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-09-02$71.01/sh−700$49,707→ 2,821,370 total(indirect: By Trust) - Sale
Common Stock
2025-09-02$70.52/sh−39,300$2,771,326→ 2,822,070 total(indirect: By Trust)
Footnotes (4)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $69.97 to $70.96 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
- [F4]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $70.97 to $71.085 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.